perspectives and therapeutic implications in treatment of scabies
Clicks: 8
ID: 182904
2008
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
2.1
/100
8 views
5 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #73 of 78 articles by views in New England Journal of Medicine
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Limited effective treatments are emerging for treatment of scabies. There was an impression that ivermectin would be always (or almost always) effective, but as it should be expected, resistant strains are being found. Molecular studies are defining better targets in the mites and we begin to understand mechanisms of resistance on them. However, we are in need of more information on the biology of those parasites.
| Reference Key |
pasternak2008einsteinperspectives
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Jacyr Pasternak |
| Journal | New England Journal of Medicine |
| Year | 2008 |
| DOI |
DOI not found
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.